Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
17.79
-0.31 (-1.71%)
At close: Mar 24, 2026, 4:00 PM EDT
17.92
+0.13 (0.73%)
After-hours: Mar 24, 2026, 7:55 PM EDT
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $1.77 billion as of March 24, 2026. Its market cap has increased by 244.55% in one year.
Market Cap
1.77B
Enterprise Value
1.40B
1-Year Change
244.55%
Ranking
Category
Stock Price
$17.79
Market Cap Chart
Since March 4, 2020, Definium Therapeutics's market cap has increased from $595.37M to $1.77B, an increase of 197.91%. That is a compound annual growth rate of 19.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 1.80B | 36.81% |
| Dec 31, 2025 | 1.32B | 158.44% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mineralys Therapeutics | 1.89B |
| Enliven Therapeutics | 1.86B |
| Sarepta Therapeutics | 1.85B |
| Mesoblast | 1.85B |
| AnaptysBio | 1.81B |
| Ultragenyx Pharmaceutical | 1.79B |
| Ocular Therapeutix | 1.76B |
| Zymeworks | 1.74B |